Purchase of polymerase chain reaction focus panels and sample kits.
Ended Awarded Last action
- Contract number
- HT942626FE065
- Awardee
-
Qiagen, LLC UEI W2GLKC92ZH73
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $33,089
Award facts
- Contract value 100% obligated
- $33,089.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- Funding agency
- Medical Command Department of the Army, Department of Defense
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Germantown, MD, USA
Award details come from SAM.gov/FPDS.
About this award
Medical Command issued a $33,089.46 delivery order to Qiagen, LLC on June 19, 2026, for polymerase chain reaction focus panels and sample kits. Place of performance is Germantown, MD, with an ultimate completion date of July 26, 2026.
Quick answers
Who was awarded contract HT942626FE065?
HT942626FE065 was awarded to Qiagen, LLC by Defense Health Agency (Department of Defense) on June 19, 2026.
How much is contract HT942626FE065 worth?
The government has obligated $33,089 on HT942626FE065.
Which agency awarded contract HT942626FE065?
Defense Health Agency (Department of Defense) awarded HT942626FE065, with funding from Medical Command (Department of the Army).
Is contract HT942626FE065 an order under another contract?
Yes. HT942626FE065 is a delivery order under W81XWH22D0010, an indefinite delivery contract.
Was contract HT942626FE065 competed?
The extent of competition for HT942626FE065 was not competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award